Biotechnology companies, especially those profitable today, face a coming decade that may be even more painful than the past decade was for global pharma, when many saw their valuations cut in half, ...

At BioCT’s 2025 legislative breakfast in January, Gov. Ned Lamont unveiled a proposed budget that includes welcome changes to Connecticut’s research and development tax credit with respect to biotech ...